Vivere Oncotherapies
Biotechnology Research • 
Berkeley, California, United States • 1-10 Employees
Company overview
| Headquarters | 2625 Durant Ave, Berkeley, California 94704, US |
| NAICS | 541714 |
| Founded | 2022 |
| Employees | 1-10 |
Key Contacts at Vivere Oncotherapies
Melissa Kotterman
Chief Executive Officer
Adam Schieferecke
Co-Founder, Head Of Discovery
Hyuncheol Lee
Co-Founder, Head Of Non-Clinical Development
About Vivere Oncotherapies
Vivere Oncotherapies’ mission is to revolutionize gene therapy delivery to unlock the full potential of immunotherapy for cold, solid tumors. Vivere Oncotherapies is developing best-in-class, IV-administered oncotherapy products with improved delivery, efficacy, and safety for the treatment of solid cancers using our proprietary discovery platform. Our experienced leadership team is applying our powerful protein engineering platform to generate improved delivery vehicles that can selectively replicate within tumors, mediate multi-tumor antigen targeting by immune cells, and express multiple cargoes that overcome the immunosuppressive environment of cold tumors. We are on a bold mission to provide solutions to patients with immunologically cold, solid tumors for which there are not effective standards of care.
Vivere Oncotherapies revenue & valuation
| Annual revenue | $598,885 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Vivere Oncotherapies has 6 employees across 5 departments.
Departments
Number of employees
Funding Data
Vivere Oncotherapies has never raised funding before.
Canada
Ireland
Germany
Australia
Frequently asked questions
4.8
40,000 users
